Identification of potential biomarkers of genotoxicity and carcinogenicity in L5178Y mouse lymphoma cells by cDNA microarray analysis

Environmental and Molecular Mutagenesis

Volumn 45, Issue 1, 2005, Pages 80-89

  Kim, Ji Young ^a   Kwon, Jung ^a   Ja, Eun Kim ^b   Woo, Suk Koh ^a   Chung, Moon Koo ^a   Yoon, Seokjoo ^a   Chang, Woo Song ^a   Lee, Michael ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Carcinogenicity; cDNA array; Gene expression, real time PCR; Genotoxicity

Indexed keywords

1,2 DICHLOROBENZENE; 8 QUINOLINOL; BIOLOGICAL MARKER; CARBAMIC ACID METHYL ESTER; CARCINOGEN; EMODIN; ETHANE; GLYCIDOL; MANNITOL; TOLUENE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE; CELL FUNCTION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENOTOXICITY; IMMUNE RESPONSE; LYMPHOMA CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; CARCINOGENICITY TESTS; CARCINOGENS; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; LEUKEMIA L5178; MICE; MICROARRAY ANALYSIS; MUTAGENICITY TESTS; MUTAGENS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 13444292818     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20077     Document Type: Article

References (44)

1. Alden CL. 2000. Safety assessment for non-genotoxic rodent carcinogens: curves, low-dose extraploations, and mechanisms in carcinogenesis. Hum Exp Toxicol 19:557-560.
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Staudt LM, et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511.
3. Adra CN, Zhu S, Ko JL, Guillemot JC, Cuervo AM, Kobayshi H, Horiuchi T, Lelias JM, Rowley JD, Lim B. 1996. LAPTM5: a novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells. Genomics 35:328-337.
4. Bierhuizen MFA, Mattei M-G, Fukuda M. 1993. Expression of the developmental I antigen by a cloned human cDNA encoding a member of a beta-1,6-N-acetylglucosaminyltransferase gene family. Genes Dev 7:468-478.
5. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V. 2000. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536-540.
6. Brown PO, Botstein D. 1999. Exploring the new world of the genome with DNA microarrays. Nat Genet 21:33-37.
7. Cabibbo A, Consalez GG, Sardella M, Sitia R, Rubartelli A. 1998. Changes in gene expression during growth arrest of hepG2 hepatoma cells induced by reducing agents or TGBβ1. Oncogene 16:2935-2943.
8. +/-)-3.7.2C mouse lymphoma cells. Mutagenesis 13:427-434.
9. +/- mouse lymphoma mutagen assay system. Mutat Res 59:61-108.
10. Cohen SD, Khairallah EA. 1997. Selective protein arylation and acetaminophen-induced hepatotoxicity. Drug Metab Rev 29:59-77.
11. Combes RD. 2000. The use of structure-activity relationships and markers of cell toxicity to detect non-genotoxic carcinogens. Toxixol In Vitro 14:387-399.
12. Doutheil J, Althausen S, Gissel C, Paschen W. 1999. Activation of MYD116 (gadd34) expression following transient forebrain ischemia of rat: implications for a role of disturbances of endoplasmic reticulum calcium homeostasis. Mol Brain Res 63:225-232.
13. Eisen MB, Spellman PT, Brown PO, Bostein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
14. Farr S, Dunn RT II. 1999. Concise review: gene expression applied to toxicology. Toxicol Sci 50:1-9.
15. Fielden MR, Zacharewski TR. 2001. Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. Toxicol Sci 60:6-10.
16. Flatmark K, Pedersen KB, Nesland JM, Rasmussen H, Aamodt G, Mikalsen SO, Bjornland K, Fodstad O, Maelandsmo GM. 2003. Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer. J Pathol 200:589-595.
17. Flores ER, Tsai KY, Crowley D, Sengupta ST, Yang A, McKeon F, Jacks T. 2002. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416:560-564.
18. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, SAnderson DM, Giri JG. 1994. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965-968.
19. Hong HL, Ton TV, Devereux TR, Moomaw C, Clayton N, Chan P, Dunnick JK, Sills RC. 2003. Chemical-specific alterations in ras, p53, and β-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years. Toxicol Appl Pharmacol 191:227-234.
20. Huang LJ, Durick K, Weiner JA, Chun J, Taylor SS. 1997. D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain. Proc Natl Acad Sci USA 94:11184-11189.
21. Kim DR, Dai Y, Mundy C, Yang W, Oettinger MA. 1999. Mutations of acidic residues in RAG1 define the active site of the V(D)J recombinase. EMBO J 13:3070-3080.
22. Komuro J, Schalling M, Jahn L, Bodmer R, Jenkins NA, Copeland GA, Izumo S. 1993. Gtx: a novel murine homeobox-containing gene, expressed specifically in glial cells of the brain and germ cells of testis, has a transcriptional repressor activity in vitro for a serum-inducible promoter. EMBO J 12:1387-1401.
23. Kothapalli R, Yoder SJ, Mane S, Loughran Jr TP. 2002. Microarray results: how accurate are they? BMC Bioinformatics 3:22-31.
24. Lee M, Kwon J, Chung MK. 2003a. Enhanced prediction of potential rodent carcinogenicity by utilizing comet assay and apoptotic assay in combination. Mutat Res 541:9-19.
25. Lee M, Kwon J, Kim SN, Kim JE, Koh WS, Kim E-J, Chung MK, Han S-S, Song CW. 2003b. cDNA microarray gene expression profiling of hydroxyurea, paclitaxel, and p-anisidine, genotoxic compounds with differing tumorigenicity results. Environ Mol Mutagen 42:91-97.
26. Ma J, Bradbury JA, King L, Maronpot R, Davis LS, Breyer MD, Zeldin DC. 2002. Molecular cloning and characterization of mouse CYP2J6, an unstable cytochrome P450 isoform. Biochem Pharmacol 64:1447-1460.
27. Maeda K, Uysal KT, Makowski L, Gorgun CZ, Atsumi G, Parker RA, Bruning J, Hertzel AV, Bernlohr DA, Hotmisligil GS. 2003. Role of the fatty acid binding protein mall in obesity and insulin resistance. Diabetes 52:300-307.
28. - mouse lymphoma cell forward mutation assay. Environ Mol Mutagen 11:91-118.
29. Minamoto T, Mai M, Ronai Z. 1999. Environmental factors as regulators and effectors of multistep carcinogenesis. Carcinogenesis 20:519-527.
30. Muller SO, Eckert I, Lutz WK, Stopper H. 1996. Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: topoisomerase II mediated? Mutat Res 371:165-173.
31. Myhr BC, Caspary WJ. 1991. Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: results for 31 coded compounds in the National Toxicology Program. Environ Mol Mutagen 18:51-83.
32. Pennie WD, Kimber I. 2002. Toxicogenomics: transcript profiling and potential application to chemical allergy. Toxicol In Vitro 16:319-326.
33. Purohit R, McCormick D, Dyson J. 1996. Multiple translation initiation factor Sui related sequences in mammalian genomes. Mamm Genome 7:79-80.
34. Rajeevan MS, Vernon SD, Taysavang N, Unger ER. 2001. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 3:26-31.
35. Rosenkranz HS. 2003. A data mining approach for the elucidation of the action of putative etiological agents: application to the non-genotoxic carcinigenicity of genistein. Mutat Res 526:85-92.
36. Sharma S, Wang J, Huang M, Paul RW, Lee P, McBride WH, Economou JS, Roth MD, Kiertscher SM, Dubinett SM. 1996. Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity. Cancer Gene Ther 3:302-313.
37. Tennant RW, Margolin BH, Shelby MD, Zeiger E, Haseman JK, Spalding J, Caspary W, Resnick M, Stasiewicz S, Anderson B, et al. 1987. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236:933-941.
38. Thompson ED, Coppinger WJ, Piper CE, McCarroll N, Oberly TJ, Robinson D. 1981. Mutagenicity of alkyl glycidyl ethers in three short-term assays. Mutat Res 90:213-231.
39. Tusher V, Tibshirani R, Chu C. 2001. Significance analysis of microarrays applied to ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121.
40. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP. 2002. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucl Acids Res 30:E15.
41. Young RR. 2002. Genetix toxicology: Web resources. Toxicology 173:103-121.
42. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. 1993. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1-beta-converting enzyme. Cell 75:641-652.
43. Zeiger E, Haseman JK, Shelby MD, Margolin BH, Tennant RW. 1990. Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals. Environ Mol Mutagen 16:1-14.
44. Zhu X, Naz RK. 1997. Fertilization antigen-1: cDNA cloning, testis-specific expression, and immunocontraceptive effects. Proc Natl Acad Sci USA 94:4704-4709.